Inotiv Inc (NOTV)
1.71
-0.05
(-2.84%)
USD |
NASDAQ |
Jun 17, 14:16
Inotiv Accounts Receivable (Quarterly): 55.02M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 55.02M |
December 31, 2023 | 78.47M |
September 30, 2023 | 77.62M |
June 30, 2023 | 74.49M |
March 31, 2023 | 65.13M |
December 31, 2022 | 65.56M |
September 30, 2022 | 88.87M |
June 30, 2022 | 94.33M |
March 31, 2022 | 78.46M |
December 31, 2021 | 66.77M |
September 30, 2021 | 22.84M |
June 30, 2021 | 15.49M |
March 31, 2021 | 9.34M |
December 31, 2020 | 8.937M |
September 30, 2020 | 8.681M |
June 30, 2020 | 8.312M |
March 31, 2020 | 9.109M |
December 31, 2019 | 9.498M |
September 30, 2019 | 7.178M |
June 30, 2019 | 6.261M |
March 31, 2019 | 4.149M |
December 31, 2018 | 3.665M |
September 30, 2018 | 4.128M |
June 30, 2018 | 3.206M |
March 31, 2018 | 2.726M |
Date | Value |
---|---|
December 31, 2017 | 2.267M |
September 30, 2017 | 2.53M |
June 30, 2017 | 2.059M |
March 31, 2017 | 2.721M |
December 31, 2016 | 2.45M |
September 30, 2016 | 1.649M |
June 30, 2016 | 2.497M |
March 31, 2016 | 2.63M |
December 31, 2015 | 1.591M |
September 30, 2015 | 2.904M |
June 30, 2015 | 3.227M |
March 31, 2015 | 3.029M |
December 31, 2014 | 2.838M |
September 30, 2014 | 2.557M |
June 30, 2014 | 2.646M |
March 31, 2014 | 2.735M |
December 31, 2013 | 2.396M |
September 30, 2013 | 3.621M |
June 30, 2013 | 2.777M |
March 31, 2013 | 2.436M |
December 31, 2012 | 2.002M |
September 30, 2012 | 3.366M |
June 30, 2012 | 3.672M |
March 31, 2012 | 3.333M |
December 31, 2011 | 3.353M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
6.261M
Minimum
Jun 2019
94.33M
Maximum
Jun 2022
42.52M
Average
38.93M
Median
Accounts Receivable (Quarterly) Benchmarks
Biolase Inc | 5.687M |
Akoya Biosciences Inc | 13.47M |
Durect Corp | 1.02M |
Macrogenics Inc | 7.219M |
Candel Therapeutics Inc | -- |